DK0787002T3 - Kompetitive progesteronantagonister til behovsorienteret fertilitetskontrol hos kvinder - Google Patents
Kompetitive progesteronantagonister til behovsorienteret fertilitetskontrol hos kvinderInfo
- Publication number
- DK0787002T3 DK0787002T3 DK95937845T DK95937845T DK0787002T3 DK 0787002 T3 DK0787002 T3 DK 0787002T3 DK 95937845 T DK95937845 T DK 95937845T DK 95937845 T DK95937845 T DK 95937845T DK 0787002 T3 DK0787002 T3 DK 0787002T3
- Authority
- DK
- Denmark
- Prior art keywords
- oriented
- women
- needs
- progesterone antagonists
- competitive progesterone
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4438820 | 1994-10-24 | ||
| PCT/EP1995/004191 WO1996012494A1 (de) | 1994-10-24 | 1995-10-24 | Kompetitive progesteronantagonisten zur bedarfsorientierten weiblichen fertilitätskontrolle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0787002T3 true DK0787002T3 (da) | 2007-04-10 |
Family
ID=6532105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95937845T DK0787002T3 (da) | 1994-10-24 | 1995-10-24 | Kompetitive progesteronantagonister til behovsorienteret fertilitetskontrol hos kvinder |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6143754A (da) |
| EP (1) | EP0787002B1 (da) |
| JP (1) | JPH10507461A (da) |
| KR (1) | KR970706827A (da) |
| CN (1) | CN1211087C (da) |
| AT (1) | ATE347894T1 (da) |
| AU (1) | AU707235B2 (da) |
| BG (1) | BG62877B1 (da) |
| BR (1) | BR9509478A (da) |
| CA (1) | CA2203541A1 (da) |
| CZ (1) | CZ290690B6 (da) |
| DE (1) | DE59511071D1 (da) |
| DK (1) | DK0787002T3 (da) |
| ES (1) | ES2279515T3 (da) |
| FI (1) | FI971742A0 (da) |
| HU (1) | HU226566B1 (da) |
| IL (1) | IL115738A (da) |
| NO (1) | NO314437B1 (da) |
| NZ (1) | NZ295365A (da) |
| PL (1) | PL319869A1 (da) |
| PT (1) | PT787002E (da) |
| RO (1) | RO120606B1 (da) |
| SK (1) | SK283662B6 (da) |
| WO (1) | WO1996012494A1 (da) |
| ZA (1) | ZA959008B (da) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19745085A1 (de) * | 1997-10-11 | 1999-04-15 | Jenapharm Gmbh | 11ß-Benzaldoxim-9alpha,10alpha-epoxy-estr-4-en-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate |
| DE19809845A1 (de) * | 1998-03-03 | 1999-09-09 | Jenapharm Gmbh | S-substituierte 11beta-Benzaldoxim-estra-4,9-dien-kohlensäurethiolester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
| UA75339C2 (en) * | 1999-08-31 | 2006-04-17 | Schering Ag | Use of mesoprogestins (progesterone receptor modulators) as pharmaceutical components for manufacture of medicament for hormone replacement therapy (hrt) |
| US7629334B1 (en) | 1999-08-31 | 2009-12-08 | Bayer Schering Pharma Aktiengesellschaft | Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT) |
| HUP0202515A3 (en) * | 1999-08-31 | 2004-06-28 | Schering Ag | Mesoprogestins (progesterone receptor modulators) as a component of female contraceptives |
| DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| JP2011507853A (ja) * | 2007-12-20 | 2011-03-10 | テバ ウィメンズ ヘルス インコーポレイテッド | 緊急避妊のための投与量レジメンならびに薬学的組成物およびパッケージ |
| ES2574999T3 (es) * | 2009-04-14 | 2016-06-23 | Laboratoire Hra-Pharma | Método para la contracepción a demanda usando levonorgestrel o norgestrel |
| BRPI1014035A2 (pt) | 2009-04-14 | 2016-04-12 | Hra Pharma Lab | método para contracepção. |
| AU2014270596A1 (en) | 2013-05-23 | 2015-12-03 | Bayer Pharma Aktiengesellschaft | Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception |
| KR20170084086A (ko) * | 2014-11-17 | 2017-07-19 | 아르노 테라퓨틱스 인코포레이티드 | 오나프리스톤 연장-방출 조성물 및 방법 |
| EP3353148A4 (en) | 2015-09-25 | 2019-04-24 | Context Biopharma Inc. | PROCESS FOR THE PRODUCTION OF ONAPRISTONE INTERMEDIATE PRODUCTS |
| KR20180113988A (ko) * | 2015-12-15 | 2018-10-17 | 컨텍스트 바이오파마 인코포레이티드 | 비정질 오나프리스톤 조성물 및 그 제조방법 |
| WO2018102369A1 (en) | 2016-11-30 | 2018-06-07 | Arno Therapeutics, Inc. | Methods for onapristone synthesis dehydration and deprotection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5439913A (en) * | 1992-05-12 | 1995-08-08 | Schering Aktiengesellschaft | Contraception method using competitive progesterone antagonists and novel compounds useful therein |
-
1995
- 1995-10-24 SK SK518-97A patent/SK283662B6/sk unknown
- 1995-10-24 EP EP95937845A patent/EP0787002B1/de not_active Expired - Lifetime
- 1995-10-24 PL PL95319869A patent/PL319869A1/xx unknown
- 1995-10-24 CA CA002203541A patent/CA2203541A1/en not_active Abandoned
- 1995-10-24 JP JP8513655A patent/JPH10507461A/ja active Pending
- 1995-10-24 BR BR9509478A patent/BR9509478A/pt active Search and Examination
- 1995-10-24 ES ES95937845T patent/ES2279515T3/es not_active Expired - Lifetime
- 1995-10-24 PT PT95937845T patent/PT787002E/pt unknown
- 1995-10-24 RO RO97-00635A patent/RO120606B1/ro unknown
- 1995-10-24 DK DK95937845T patent/DK0787002T3/da active
- 1995-10-24 CN CNB951958178A patent/CN1211087C/zh not_active Expired - Fee Related
- 1995-10-24 DE DE59511071T patent/DE59511071D1/de not_active Expired - Fee Related
- 1995-10-24 IL IL11573895A patent/IL115738A/en not_active IP Right Cessation
- 1995-10-24 WO PCT/EP1995/004191 patent/WO1996012494A1/de active IP Right Grant
- 1995-10-24 CZ CZ19971180A patent/CZ290690B6/cs not_active IP Right Cessation
- 1995-10-24 ZA ZA959008A patent/ZA959008B/xx unknown
- 1995-10-24 NZ NZ295365A patent/NZ295365A/xx unknown
- 1995-10-24 AU AU38696/95A patent/AU707235B2/en not_active Ceased
- 1995-10-24 HU HU9702177A patent/HU226566B1/hu not_active IP Right Cessation
- 1995-10-24 AT AT95937845T patent/ATE347894T1/de not_active IP Right Cessation
-
1997
- 1997-04-21 BG BG101427A patent/BG62877B1/bg unknown
- 1997-04-23 NO NO19971869A patent/NO314437B1/no unknown
- 1997-04-23 FI FI971742A patent/FI971742A0/fi unknown
- 1997-04-24 KR KR1019970702695A patent/KR970706827A/ko active Search and Examination
-
1999
- 1999-03-22 US US09/273,485 patent/US6143754A/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0787002T3 (da) | Kompetitive progesteronantagonister til behovsorienteret fertilitetskontrol hos kvinder | |
| FI963049A0 (fi) | Progesteroniantagonisteja lääkeaineiden valmistamiseksi, jotka on tarkoitettu kohdun toimintahäiriöistä johtuvien verenvuotojen hoitamiseksi | |
| ATE217192T1 (de) | Kombinationsprodukt zur kontrazeption enthaltend progesteronantagonisten und gestagenen | |
| EP0402950A3 (en) | Treatment of postmenopausal disorders | |
| IS4407A (is) | Notkun samsetningarafurðar sem inniheldur samkeppnishæf prógesterónmótlyf og gestagen til framleiðslu á læknislyfi til meðhöndlunar á legslímuvillu eða bandvefsvöðvahnútum í legi | |
| DE59610462D1 (de) | Pharmazeutisches kombinationspräparat zur hormonalen kontrazeption | |
| DE69519933T2 (de) | Prostaglandinanaloga zur oralen oder vaginalen verabreichung in der routinebehandlung des dritten stadiums der geburtswehen | |
| PT730448E (pt) | Utilizacao de um substrato de sintetase e/ou dador de oxido nitrico ou um inibidor de oxido nitrico para o fabrico de medicamentos para o tratamento de desordens da contractilidade uterina | |
| HUP9900313A1 (hu) | Antiösztrogének alkalmazása hím nemzőképesség szabályozására | |
| Board et al. | Sequential oral contraception using DMAP | |
| DE50003993D1 (de) | Verwendung von dienogest in hoher dosierung | |
| Suran | Ovulation inhibition with sequential therapy. A continuing clinical study of fertility control | |
| JPS56123052A (en) | Multiprocessor system | |
| Crist | Post-coital estrogen |